Page last updated: 2024-08-24

ranolazine and Auricular Fibrillation

ranolazine has been researched along with Auricular Fibrillation in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (5.95)	29.6817
2010's	71 (84.52)	24.3611
2020's	8 (9.52)	2.80

Authors

Authors	Studies
de Lima Conceição, MR; Leal-Silva, P; Roman-Campos, D; Teixeira-Fonseca, JL	1
Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S	1
Baier, MJ; Kozakov, K; Lebek, S; Maier, LS; Mustroph, J; Neef, S; Provaznik, Z; Schildt, S; Tarnowski, D; Unsin, D; Voigt, N; Wagner, S	1
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Molyvdas, PA; Simopoulos, V; Stamatiou, R; Stravela, S	1
Belardinelli, L; Dhalla, A; Opačić, D; Schotten, U; van Hunnik, A; Verheule, S; Zeemering, S	1
Buhl, R; Jespersen, T; Saljic, A	1
Hui, Q; Luo, W; Ren, X; Ya, M; Yan, W; Yuan, C	1
Abi-Gerges, N; Cotta, T; Espinoza, A; Geft, V; Ghetti, A; Hernandez, E; Indersmitten, T; Macias, A; Mai, C; Miller, PE; Miron, Y; Nguyen, W; Page, G; Rasoul, L; Stafford, A; Sweat, K; Ton, AT; Truong, K; Wong, T	1
Ariano, C; Cioppa, C; De Vecchis, R; Giasi, A	1
Burashnikov, A	1
Bögeholz, N; Dechering, DG; Eckardt, L; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M	1
Buhl, R; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Kanters, JK; Kjær, L; Pehrson, S	1
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Kohnke, A; Reinke, F	1
Chang, CJ; Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Higa, S; Huang, JH	1
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Hevas, A; Simopoulos, V; Skoularigis, I; Tsilimingas, N	1
Buhl, R; Carlson, J; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Pehrson, S; Platonov, PG	1
Aidonidis, I; Chryssagis, K; Daskalopoulos, ME; Daskalopoulou, SS; Lenos, A; Molyvdas, PA; Simopoulos, V; Skoularingis, I; Tagarakis, GI; Tsilimingas, NB	1
Jacobshagen, C	1
Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Uphaus, T	1
Da Costa, D; Kolasa, M; Koyama, G; McGregor, P; Shah, SA	1
Fragakis, N; Katritsis, D; Koskinas, KC; Skeberis, V; Vassilikos, V	1
Banach, M; Mariscalco, G	1
Ravens, U	1
Lee, S; Tsu, LV	1
Anastasiou-Nana, M; Dagres, N; Iliodromitis, EK; Karatzas, D; Lekakis, JP; Rallidis, LS; Simeonidou, E; Simitsis, P	1
Balestrini, F; Fallavollita, L; Marini, L; Migale, M; Postacchini, D; Santillo, E	1
Antzelevitch, C; Barajas-Martínez, H; Belardinelli, L; Burashnikov, A; Cordeiro, JM; Di Diego, JM; Hu, D; Kornreich, BG; Moise, NS; Zygmunt, AC	1
Belardinelli, L; Bhimani, AA; Khrestian, CM; Lee, S; Sadrpour, SA; Waldo, AL; Yasuda, T; Zeng, D	1
Fragakis, N; Koskinas, KC; Vassilikos, V	1
Belardinelli, L; Braunwald, E; Chaitman, BR; Cheng, ML; Karwatowska-Prokopczuk, E; Morrow, DA; Murphy, SA; Scirica, BM; Volo, S; Waks, JW	1
Batatinha, JA; Belardinelli, L; Bonatti, R; Liu, G; Nearing, BD; Rajamani, S; Silva, AF; Verrier, RL; Zeng, D	1
DeLosSantos, M; Hammond, DA; Jankowski, CA; Kraemer, D; Osian, O; Smotherman, C; Tan, S	1
Diness, JG; Grunnet, M; Jespersen, T; Kirchhoff, JE; Sheykhzade, M	1
Daniels, JD; Hill, JA	1
Alberto Maggi, C; Boriani, G; Camm, AJ; Darius, H; De Ferrari, GM; Dusi, V; Giannelli, S; Gronda, E; Guillamón Torán, L; Leschke, M; Maier, LS; Marchionni, N; Melani, L; Mont, L; Quintana Rendón, M; Savelieva, I; Schumacher, K; Schwartz, PJ; Simonis, G; Tonini, G	1
Aronow, WS; Gupta, T; Iwai, S; Khera, S; Kolte, D	1
Bertero, G; Brunacci, M; Brunelli, C; Dorighi, U; Ferrero, S; Rosa, GM	1
Fabritz, L; Grunnet, M; Jespersen, T; Knaut, M; Matschke, K; Poulet, C; Ravens, U; Wettwer, E	1
Belardinelli, L; Camm, AJ; Karwatowska-Prokopczuk, E; Kowey, P; Olmsted, A; Reiffel, JA; Rosero, S; Zareba, W; Zeng, D	1
Capucci, A; Guerra, F; Matassini, MV; Scappini, L; Urbinati, A	1
Chen, Y; Geng, N; Guo, S; Liu, X; Ren, L; Wan, J; Wang, S; Zou, D	1
Fragakis, N; Gong, M; Korantzopoulos, P; Letsas, KP; Li, G; Liu, T; Yan, GX; Zhang, Z	1
Barnett, AS; Black-Maier, EW; Daubert, JP; Goldberger, JJ; Grant, AO; Liu, P; Ng, J; Piccini, JP; Pokorney, SD; Shrader, P; Zareba, W	1
Nguyen, E; White, CM	1
Banerjee, A; Banerjee, K; Ghosh, RK; Gupta, A; Kamatam, S	1
Barbarossa, A; Belardinelli, L; Capucci, A; Guerra, F; Romandini, A	1
Vitaliivna Kuzminova, N; Yuriivna Osovska, N	1
Aidonidis, I; Daskalopoulou, SS; Giamouzis, G; Hatziefthimiou, A; Skoularigis, I; Triposkiadis, F; Tsanaxidis, N	1
Acar, M; Belardinelli, L; Carvas, M; Kumar, K; Nascimento, BC; Nearing, BD; Verrier, RL	1
Foster, NJ; Haines, DE	1
Doshi, D; Morrow, JP	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Sicouri, S	1
Acar, M; Belardinelli, L; Carvas, M; Nascimento, BC; Nearing, BD; Verrier, RL	1
Dobrev, D; Nattel, S	1
Greiser, M; Kerfant, BG; Schotten, U; Verheule, S	1
Belardinelli, L; Hasenfuss, G; Kallmeyer, B; Maier, LS; Maurer, U; Mazur, M; Schmitto, JD; Schöndube, FA; Seipelt, R; Sossalla, S; Toischer, K; Wagner, S	1
Baez-Escudero, JL; Beshai, JF; Burke, MC; Shah, DP; Weisberg, IL	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Sicouri, S	1
Hoppe, UC; Kochanek, M; Michels, G	1
Doggrell, SA; Hancox, JC	1
Brachmann, J; Ritscher, G; Simon Demel, K; Simon, H; Turschner, O	1
Reddy, BM; Schwartzbard, AZ; Weintraub, HS	1
Miles, RH; Murdock, DK; Passman, R	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A	1
Antzelevitch, C; Gibson, JK; Lynch, JJ; Pourrier, M; Sicouri, S	1
Franz, MR; Singh, SN	1
Kaliebe, J; Larrain, G; Murdock, DK	1
Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Lu, YY	1
Mullard, A	1
Antzelevitch, C; Belardinelli, L; Blazek, J; Sicouri, S	1
Fragakis, N; Geleris, P; Katritsis, DG; Koskinas, KC; Pagourelias, ED; Zografos, T	1
Maier, LS	2
Aidonidis, I; Doulas, K; Hatziefthimiou, A; Molyvdas, PA; Rizos, I; Simopoulos, V; Tagarakis, G; Tsilimingas, N	1
Andrikopoulos, G; Tzeis, S	1
Saklani, P; Skanes, A	1
Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D	1
Clauß, C; Eckardt, L; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Schmidt, M; Stypmann, J	1
Aidonidis, I; Daskalopoulos, ME; Daskalopoulou, SS; Liouras, V; Molyvdas, PA; Papageorgiou, K; Parisis, C; Simopoulos, V; Skoularingis, I; Tagarakis, GI; Triposkiadis, F; Tsilimingas, NB	1
Lüthje, L; Seegers, J; Sohns, C; Sossalla, S; Vollmann, D; Zabel, M	1
Belardinelli, L; Kumar, K; Nieminen, T; Verrier, RL	1
Belardinelli, L; Breithardt, G; Eckardt, L; Frommeyer, G; Ghezelbash, S; Milberg, P; Osada, N; Rajamani, S; Razvan, R	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Zygmunt, AC	2

Reviews

27 review(s) available for ranolazine and Auricular Fibrillation

Article	Year
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:4 Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil	2023
Anti-arrhythmic investigations in large animal models of atrial fibrillation. British journal of pharmacology, 2022, Volume: 179, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Flecainide; Horses; Mammals; Models, Animal; Ranolazine; Swine	2022
Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis. Minerva cardioangiologica, 2018, Volume: 66, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Ranolazine	2018
Late INa Inhibition as an Antiarrhythmic Strategy. Journal of cardiovascular pharmacology, 2017, Volume: 70, Issue:3 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Ranolazine; Sodium Channel Blockers; Sodium Channels	2017
[Late sodium current and calcium overload--pathogenesis and adequate treatment]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:16 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger	2013
[New developments in the antiarrhythmic therapy of atrial fibrillation]. Herzschrittmachertherapie & Elektrophysiologie, 2014, Volume: 25, Issue:1 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Dronedarone; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Piperazines; Pyrrolidines; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2014
Use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5 Topics: Acetanilides; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Piperazines; Postoperative Complications; Ranolazine; Sodium Channel Blockers	2014
Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review. Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:3 Topics: Acetanilides; Acute Coronary Syndrome; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Coronary Artery Bypass; Electric Countershock; Humans; Piperazines; Ranolazine; Recurrence	2014
Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications. Pacing and clinical electrophysiology : PACE, 2014, Volume: 37, Issue:10 Topics: Acetanilides; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiological Phenomena; Humans; Piperazines; Ranolazine	2014
Antiarrhythmic properties of ranolazine: A review of the current evidence. International journal of cardiology, 2015, Volume: 187 Topics: Atrial Fibrillation; Heart Conduction System; Humans; Ranolazine; Sodium Channel Blockers	2015
Ranolazine for the treatment of atrial fibrillation. Expert opinion on investigational drugs, 2015, Volume: 24, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Ranolazine	2015
New anthyarrhythmic drugs for atrial fibrillation. Future cardiology, 2015, Volume: 11, Issue:6 Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Pyrrolidines; Ranolazine	2015
Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials. Heart rhythm, 2017, Volume: 14, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Humans; Male; Prognosis; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome	2017
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Clinical Trials as Topic; Dronedarone; Drug Therapy, Combination; Humans; Male; Ranolazine; Recurrence; Treatment Outcome	2017
Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina. International journal of cardiology, 2017, Jan-15, Volume: 227 Topics: Aged; Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Role; Sodium Channel Blockers; Survival Analysis; Treatment Outcome	2017
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis. International journal of cardiology, 2017, Jan-15, Volume: 227 Topics: Atrial Fibrillation; Cardiovascular Agents; Humans; Ranolazine	2017
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016, Dec-22, Volume: 41, Issue:246 Topics: Adult; Angina, Stable; Atrial Fibrillation; Bundle-Branch Block; Cardiovascular Agents; Female; Humans; Microvascular Angina; Middle Aged; Ranolazine; Treatment Outcome	2016
The antiarrhythmic effects of ranolazine. Reviews in cardiovascular medicine, 2009, Volume: 10 Suppl 1 Topics: Acetanilides; Acute Coronary Syndrome; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart Conduction System; Humans; Long QT Syndrome; Piperazines; Potassium Channel Blockers; Ranolazine; Sick Sinus Syndrome; Sodium Channel Blockers; Treatment Outcome	2009
Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation. Reviews in cardiovascular medicine, 2009, Volume: 10 Suppl 1 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Conduction System; Heart Failure; Humans; Myocytes, Cardiac; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Treatment Outcome	2009
New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Dronedarone; Humans; Piperazines; Pyrrolidines; Ranolazine; Renin-Angiotensin System	2010
[Ranolazine--an additional anti-anginal drug]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:41 Topics: Acetanilides; Angina Pectoris; Atrial Fibrillation; Biological Availability; Blood Pressure; Double-Blind Method; Enzyme Inhibitors; Heart Failure, Diastolic; Heart Rate; Humans; Metabolic Clearance Rate; Piperazines; Randomized Controlled Trials as Topic; Ranolazine	2010
Perspective: does ranolazine have potential for the treatment of atrial fibrillation? Expert opinion on investigational drugs, 2010, Volume: 19, Issue:12 Topics: Acetanilides; Animals; Atrial Fibrillation; Clinical Trials as Topic; Drug Evaluation, Preclinical; Evidence-Based Medicine; Humans; Ion Channel Gating; Piperazines; Ranolazine; Treatment Outcome	2010
[New developments in the antiarrhythmic therapy of atrial fibrillation]. Herzschrittmachertherapie & Elektrophysiologie, 2010, Volume: 21, Issue:4 Topics: Acetanilides; Aged; Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Electrocardiography; Heart Atria; Heart Failure; Heart Ventricles; Humans; Piperazines; Potassium Channels; Pyrrolidines; Ranolazine; Sodium Channels; Stroke	2010
Ranolazine: a new approach to treating an old problem. Texas Heart Institute journal, 2010, Volume: 37, Issue:6 Topics: Acetanilides; Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Evidence-Based Medicine; Heart Diseases; Heart Failure, Diastolic; Humans; Myocardial Infarction; Piperazines; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2010
New treatment options for late Na current, arrhythmias, and diastolic dysfunction. Current heart failure reports, 2012, Volume: 9, Issue:3 Topics: Acetanilides; Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Calcium; Cardiovascular Agents; Cations; Diastole; Enzyme Inhibitors; Heart Failure; Heart Failure, Diastolic; Humans; Myocardial Contraction; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Sodium; Sodium-Calcium Exchanger	2012
Novel anti-arrhythmic medications in the treatment of atrial fibrillation. Current cardiology reviews, 2012, Volume: 8, Issue:4 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left	2012
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:3 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Electrocardiography; Heart Conduction System; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Treatment Outcome; Ventricular Fibrillation	2013

Trials

9 trial(s) available for ranolazine and Auricular Fibrillation

Article	Year
Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients. Cardiovascular drugs and therapy, 2018, Volume: 32, Issue:6 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug Therapy, Combination; Female; Greece; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Ranolazine; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2018
Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery. Angiology, 2014, Volume: 65, Issue:4 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Elective Surgical Procedures; Female; Greece; Humans; Infusions, Intravenous; Male; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Single-Blind Method; Time Factors; Treatment Outcome	2014
Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:7 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Greece; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Single-Blind Method; Time Factors; Treatment Outcome	2014
Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015, Volume: 17, Issue:1 Topics: Acetanilides; Acute Coronary Syndrome; Age Distribution; Aged; Aged, 80 and over; Atrial Fibrillation; Comorbidity; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Massachusetts; Piperazines; Placebo Effect; Prevalence; Ranolazine; Risk Factors; Sodium Channel Blockers; Survival Rate; Treatment Outcome	2015
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. Heart rhythm, 2015, Volume: 12, Issue:5 Topics: Aged; Atrial Fibrillation; Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Electric Countershock; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Ranolazine; Secondary Prevention; Treatment Outcome	2015
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Circulation. Arrhythmia and electrophysiology, 2015, Volume: 8, Issue:5 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Pacemaker, Artificial; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2015
Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy. Pacing and clinical electrophysiology : PACE, 2017, Volume: 40, Issue:4 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2017
Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation. The American journal of cardiology, 2012, Sep-01, Volume: 110, Issue:5 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Piperazines; Proportional Hazards Models; Prospective Studies; Ranolazine; Safety Management; Severity of Illness Index; Treatment Outcome	2012
Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery. Current vascular pharmacology, 2013, Volume: 11, Issue:6 Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Piperazines; Postoperative Complications; Preoperative Care; Ranolazine; Single-Blind Method; Treatment Outcome	2013

Other Studies

48 other study(ies) available for ranolazine and Auricular Fibrillation

Article	Year
Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline-induced pulmonary hypertension. Basic & clinical pharmacology & toxicology, 2023, Volume: 132, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Heart Atria; Hypertension, Pulmonary; Monocrotaline; Ranolazine; Rats; Rats, Wistar	2023
Ethanol-Induced Atrial Fibrillation Results From Late Circulation, 2023, 08-22, Volume: 148, Issue:8 Topics: Atrial Fibrillation; Humans; Ranolazine	2023
Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2021, Volume: 62, Issue:1 Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Rabbits; Ranolazine	2021
Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation. Heart rhythm, 2021, Volume: 18, Issue:4 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Female; Goats; Heart Atria; Ranolazine; Sodium Channel Blockers	2021
Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis. Medicine, 2021, Apr-23, Volume: 100, Issue:16 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Meta-Analysis as Topic; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Recurrence; Risk Assessment; Secondary Prevention; Sodium Channel Blockers; Treatment Outcome	2021
Arrhythmogenic and antiarrhythmic actions of late sustained sodium current in the adult human heart. Scientific reports, 2021, 06-08, Volume: 11, Issue:1 Topics: Adult; Atrial Fibrillation; Calcium; Cnidarian Venoms; ERG1 Potassium Channel; Heart Atria; Humans; Membrane Potentials; Models, Cardiovascular; Myocytes, Cardiac; Piperidines; Pyridines; Ranolazine; Sodium; Triazoles	2021
Comparison of vernakalant and ranolazine in atrial fibrillation. Journal of cardiovascular medicine (Hagerstown, Md.), 2017, Volume: 18, Issue:9 Topics: Animals; Anisoles; Atrial Fibrillation; Cardiovascular Agents; Drug Evaluation, Preclinical; In Vitro Techniques; Pyrrolidines; Rabbits; Ranolazine	2017
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses. Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Combinations; Female; Heart Rate; Horses; Infusions, Intravenous; Male; Phenethylamines; Ranolazine; Sulfonamides	2018
Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation. Pharmacology, 2018, Volume: 102, Issue:3-4 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Interactions; Hydrazones; Pyridazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Simendan	2018
Factor Xa inhibitors differently modulate electrical activities in pulmonary veins and the sinoatrial node. European journal of pharmacology, 2018, Aug-15, Volume: 833 Topics: Action Potentials; Animals; Atrial Fibrillation; Factor Xa Inhibitors; Guanidines; Male; Microelectrodes; Models, Animal; Myocytes, Cardiac; Oligopeptides; Patch-Clamp Techniques; Pulmonary Veins; Pyridines; Rabbits; Ranolazine; Receptor, PAR-1; Rivaroxaban; Sinoatrial Node; Sodium-Calcium Exchanger; Stroke; Thiazoles	2018
Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation. Journal of cardiovascular electrophysiology, 2019, Volume: 30, Issue:4 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Horses; Male; Phenethylamines; Potassium Channel Blockers; Ranolazine; Sodium Channel Blockers; Sulfonamides; Time Factors	2019
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation. Cardiovascular therapeutics, 2013, Volume: 31, Issue:6 Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Female; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sotalol	2013
Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation. International journal of cardiology, 2014, Apr-01, Volume: 172, Issue:3 Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Humans; Male; Phenethylamines; Piperazines; Ranolazine; Sodium Channel Blockers; Sulfonamides	2014
Editorial: atrial fibrillation after coronary surgery: the need for an effective pharmacological prophylaxis. Current vascular pharmacology, 2013, Volume: 11, Issue:6 Topics: Acetanilides; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Male; Piperazines; Postoperative Complications; Ranolazine	2013
Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation. La Clinica terapeutica, 2014, Volume: 165, Issue:2 Topics: Acetanilides; Aged; Atrial Fibrillation; Female; Humans; Piperazines; Ranolazine; Treatment Outcome	2014
Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure. Circulation. Heart failure, 2014, Volume: 7, Issue:4 Topics: Acetanilides; Action Potentials; Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Heart Atria; Heart Conduction System; Heart Failure; Heart Ventricles; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Ranolazine; Sodium Channel Blockers	2014
Ranolazine terminates atrial flutter and fibrillation in a canine model. Heart rhythm, 2014, Volume: 11, Issue:9 Topics: Acetanilides; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Disease Models, Animal; Dogs; Electrocardiography; Enzyme Inhibitors; Heart Conduction System; Heart Rate; Injections, Intravenous; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2014
Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:3 Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Guinea Pigs; Heart Rate; Ivabradine; Male; Ranolazine; Swine	2015
Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries. Clinical research in cardiology : official journal of the German Cardiac Society, 2015, Volume: 104, Issue:5 Topics: Aged; Atrial Fibrillation; Cardiac Valve Annuloplasty; Cardiovascular Agents; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Germany; Heart Valve Prosthesis Implantation; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Period; Ranolazine; Retrospective Studies	2015
Synergistic antiarrhythmic effect of combining inhibition of Ca²⁺-activated K⁺ (SK) channels and voltage-gated Na⁺ channels in an isolated heart model of atrial fibrillation. Heart rhythm, 2015, Volume: 12, Issue:2 Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Guinea Pigs; Piperazines; Ranolazine; Small-Conductance Calcium-Activated Potassium Channels; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels	2015
Funny and late: targeting currents governing heart rate in atrial fibrillation. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:3 Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Rate; Male; Ranolazine	2015
Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation. PloS one, 2015, Volume: 10, Issue:6 Topics: Action Potentials; Aged; Animals; Arrhythmia, Sinus; Atrial Fibrillation; Female; Heart Atria; Humans; Ion Channel Gating; Male; Mice; Middle Aged; Myocytes, Cardiac; Protein Subunits; Ranolazine; Sodium Channels; Temperature; Tetrodotoxin	2015
Ranolazine improves oxidative stress and mitochondrial function in the atrium of acetylcholine-CaCl2 induced atrial fibrillation rats. Life sciences, 2016, Jul-01, Volume: 156 Topics: Acetylcholine; Animals; Apoptosis; Atrial Fibrillation; Calcium Chloride; Heart Atria; Hemodynamics; Male; Mitochondria; Oxidative Stress; Proto-Oncogene Proteins c-akt; Ranolazine; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases	2016
Ranolazine reduces atrial fibrillatory wave frequency. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2017, Jul-01, Volume: 19, Issue:7 Topics: Action Potentials; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Databases, Factual; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; North Carolina; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Treatment Outcome	2017
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. Journal of cardiovascular electrophysiology, 2009, Volume: 20, Issue:7 Topics: Acetanilides; Acetylcholine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Heart Conduction System; Infusions, Intravenous; Male; Piperazines; Ranolazine; Refractory Period, Electrophysiological; Swine; Time Factors	2009
Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circulation. Arrhythmia and electrophysiology, 2010, Volume: 3, Issue:1 Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Drug Synergism; Electrophysiologic Techniques, Cardiac; Enzyme Inhibitors; In Vitro Techniques; Membrane Potentials; Piperazines; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers	2010
Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart. Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:3 Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Disease Models, Animal; Female; Injections; Male; Piperazines; Ranolazine; Refractory Period, Electrophysiological; Swine; Time Factors; Ventricular Fibrillation	2010
Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon? Journal of the American College of Cardiology, 2010, May-25, Volume: 55, Issue:21 Topics: Acetanilides; Anti-Arrhythmia Agents; Atrial Fibrillation; Cells, Cultured; Drug Delivery Systems; Female; Heart Atria; Humans; Male; Myocytes, Cardiac; Piperazines; Ranolazine; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Sodium Channels	2010
Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. Journal of the American College of Cardiology, 2010, May-25, Volume: 55, Issue:21 Topics: Acetanilides; Aged; Analysis of Variance; Atrial Appendage; Atrial Fibrillation; Calcium Channels; Calcium Signaling; Cardiac Surgical Procedures; Catheter Ablation; Female; Heart Atria; Humans; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Culture Techniques; Piperazines; Probability; Ranolazine; Reference Values; Sampling Studies; Sodium Channels	2010
Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8). Pacing and clinical electrophysiology : PACE, 2012, Volume: 35, Issue:3 Topics: Acetanilides; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Autistic Disorder; Drug Therapy, Combination; Humans; Long QT Syndrome; Male; Piperazines; Ranolazine; Syndactyly; Treatment Outcome; Ventricular Fibrillation; Verapamil	2012
Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. Journal of the American College of Cardiology, 2010, Oct-05, Volume: 56, Issue:15 Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Dronedarone; Drug Synergism; Drug Therapy, Combination; Piperazines; Ranolazine	2010
Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. The American journal of cardiology, 2011, Sep-01, Volume: 108, Issue:5 Topics: Acetanilides; Aged; Amiodarone; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Enzyme Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Vasodilator Agents	2011
Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 340, Issue:1 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Diastole; Dogs; Electrophysiological Phenomena; Heart Atria; Heart Conduction System; Heart Ventricles; Kinetics; Piperazines; Propafenone; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers	2012
Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations. Heart rhythm, 2012, Volume: 9, Issue:3 Topics: Acetanilides; Action Potentials; Adrenergic beta-Agonists; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cardiac Electrophysiology; Cell Membrane; Dogs; Heart Rate; Humans; Isoproterenol; Membrane Potentials; Piperazines; Pulmonary Veins; Pyrrolidines; Ranolazine; Sodium Channels; Sotalol	2012
Comparative pharmacophysiology of vernakalant, ranolazine, and d-sotalol in canine pulmonary vein sleeve preparations: new flavors or same old taste? Heart rhythm, 2012, Volume: 9, Issue:3 Topics: Acetanilides; Animals; Anisoles; Atrial Fibrillation; Humans; Piperazines; Pulmonary Veins; Pyrrolidines; Ranolazine; Sodium Channels; Sotalol	2012
The use of ranolazine to facilitate electrical cardioversion in cardioversion-resistant patients: a case series. Pacing and clinical electrophysiology : PACE, 2012, Volume: 35, Issue:3 Topics: Acetanilides; Aged; Angina Pectoris; Atrial Fibrillation; Electric Countershock; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Treatment Outcome	2012
ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome. European journal of clinical investigation, 2012, Volume: 42, Issue:8 Topics: Acetanilides; Action Potentials; Analysis of Variance; Animals; Atrial Fibrillation; Cardiac Conduction System Disease; Cardiotonic Agents; Cnidarian Venoms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Atria; Humans; Long QT Syndrome; Models, Animal; Piperazines; Pulmonary Veins; Rabbits; Ranolazine	2012
Second chance for dronedarone after recent setback? Lancet (London, England), 2012, Feb-18, Volume: 379, Issue:9816 Topics: Acetanilides; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Contraindications; Dronedarone; Drug Approval; Drug Therapy, Combination; Electrocardiography; Europe; Humans; Piperazines; Ranolazine; Sodium Channel Blockers; Survival Analysis; United States	2012
Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine. Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:2 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Dogs; Electrophysiological Phenomena; Enzyme Inhibitors; Models, Animal; Ouabain; Piperazines; Pulmonary Veins; Ranolazine; Vena Cava, Superior	2012
Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits. Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:1 Topics: Acetanilides; Acetylcholine; Action Potentials; Anesthesia; Animals; Atrial Fibrillation; Atrial Flutter; Female; Male; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers	2013
Antiarrhythmic properties of ranolazine--from bench to bedside. Expert opinion on investigational drugs, 2012, Volume: 21, Issue:11 Topics: Acetanilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as Topic; Humans; Piperazines; Ranolazine; Tachycardia, Ventricular	2012
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. Heart rhythm, 2013, Volume: 10, Issue:1 Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Piperazines; Ranolazine; Swine; Tachycardia, Ventricular	2013
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. European journal of heart failure, 2012, Volume: 14, Issue:12 Topics: Acetanilides; Acetylcholine; Animals; Atrial Fibrillation; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Female; Heart Conduction System; Heart Failure; Isoproterenol; Piperazines; Rabbits; Ranolazine; Signal Processing, Computer-Assisted	2012
Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms! European journal of heart failure, 2012, Volume: 14, Issue:12 Topics: Acetanilides; Animals; Atrial Fibrillation; Enzyme Inhibitors; Female; Heart Failure; Piperazines; Ranolazine	2012
Ranolazine maintained sinus rhythm in a patient with refractory symptomatic atrial fibrillation. Cardiovascular therapeutics, 2013, Volume: 31, Issue:5 Topics: Acetanilides; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Heart Rate; Humans; Middle Aged; Piperazines; Ranolazine	2013
Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:5 Topics: Acetanilides; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Heart Conduction System; Heart Rate; In Vitro Techniques; Neural Conduction; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sotalol; Treatment Outcome	2013
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation, 2007, Sep-25, Volume: 116, Issue:13 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Dogs; Drug Evaluation, Preclinical; Heart Atria; Heart Ventricles; Ion Channels; Lidocaine; Myocytes, Cardiac; Organ Specificity; Patch-Clamp Techniques; Piperazines; Purkinje Fibers; Ranolazine; Sodium Channel Blockers	2007
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation. Annals of the New York Academy of Sciences, 2008, Volume: 1123 Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electrophysiology; Heart Atria; Humans; Lidocaine; Piperazines; Propafenone; Ranolazine; Sodium Channel Blockers; Ventricular Function	2008